Peptide · Approved
Thymosin alpha-1
An immune-modulating peptide (Zadaxin) approved in many countries for hepatitis and as a vaccine adjuvant; not FDA-approved.
Key facts
- Also known as: Zadaxin, thymalfasin
- Status: Approved
- Used for: Immune support
- Natural counterpart: A naturally occurring thymic peptide (from prothymosin α).
- Target enzyme / receptor: Toll-like receptors (TLR2/TLR9) on immune cells
- Signalling pathway: Enhances dendritic-cell & T-cell maturation → stronger cell-mediated immunity
In plain terms: Wakes up immune cells (T-cells, dendritic cells) to fight infection. - Crystal structure: no peptide–target complex in the PDB yet — study the target ↗
Status & safety
This is an approved medicine — prescription-only in most countries. Only use it under a licensed clinician, obtained through a pharmacy.
Research & clinical studies
Explore the biochemistry and clinical evidence for Thymosin alpha-1 — these open live, date-sorted searches, so they always show the latest.
Read research papers on PubMed ↗
Clinical studies (ClinicalTrials.gov) ↗
Google Scholar ↗
Related guide →
All peptides & profiles →
Not medical advice. Chemdu is an educational resource and does not sell, prescribe or supply any peptide. Consult a licensed professional about any medicine or supplement.